BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30217169)

  • 1. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.
    Adland E; Jesuthasan G; Downs L; Wharton V; Wilde G; McNaughton AL; Collier J; Barnes E; Klenerman P; Andersson M; Jeffery K; Matthews PC
    BMC Infect Dis; 2018 Sep; 18(1):461. PubMed ID: 30217169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.
    Nordstrom EM; Keniston A; Baouchi F; Martinez-Camacho A
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):10-16. PubMed ID: 27755117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real-life setting.
    Pischke S; Polywka S; Proske VM; Lang M; Jordan S; Nashan B; Lohse AW; Sterneck M
    Transpl Infect Dis; 2016 Feb; 18(1):141-5. PubMed ID: 26485543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Hepatitis C Cure Cascade Outcomes Among Urban Baby Boomers in the Direct-Acting Antiviral Era.
    Dupont SC; Fluker SA; Quairoli KM; Body C; Okosun I; Lom J; Miller LS
    Public Health Rep; 2020 Jan; 135(1):107-113. PubMed ID: 31756116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand.
    Supanan R; Han WM; Harnpariphan W; Ueaphongsukkit T; Ubolyam S; Sophonphan J; Tangkijvanich P; Thanprasertsuk S; Avihingsanon A;
    J Acquir Immune Defic Syndr; 2021 Dec; 88(5):465-469. PubMed ID: 34757974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system.
    Zhang M; O'Keefe D; Craig J; Samley K; Bunreth V; Jolivet P; Balkan S; Marquardt T; Dousset JP; Le Paih M
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):371-380. PubMed ID: 33743883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
    Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
    J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
    Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
    Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality.
    Wang Y; Rao H; Chi X; Li B; Liu H; Wu L; Zhang H; Liu S; Zhou G; Li N; Niu J; Wei L; Zhao J
    EBioMedicine; 2019 Aug; 46():227-235. PubMed ID: 31345785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus Infection.
    Aghemo A; Degasperi E; De Nicola S; Bono P; Orlandi A; D'Ambrosio R; Soffredini R; Perbellini R; Lunghi G; Colombo M
    Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1331-6. PubMed ID: 27046484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and monitoring of HCV infection using the cobas
    Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
    J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era.
    Hariri S; Sharafi H; Sheikh M; Merat S; Hashemi F; Azimian F; Tamadoni B; Ramazani R; Gouya MM; Abbasi B; Tashakorian M; Alasvand R; Alavian SM; Poustchi H; Malekzadeh R
    Harm Reduct J; 2020 Oct; 17(1):80. PubMed ID: 33081794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil.
    Carvalho-Louro DM; Soares EB; Trevizoli JE; Marra TMG; da Cunha ALR; Rodrigues MP; Carvalho-Furtado ACL; Dos Santos BTA; de Assis da Rocha Neves F
    BMC Infect Dis; 2020 Feb; 20(1):114. PubMed ID: 32041537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review.
    Walter LA; Wilson L; Farmer M; Roberson T; Hand DT; Franco R
    Am J Emerg Med; 2023 Oct; 72():178-182. PubMed ID: 37540919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program.
    Masarone M; Caruso R; Aglitti A; Izzo C; De Matteis G; Attianese MR; Pagano AM; Persico M
    Dig Liver Dis; 2020 May; 52(5):541-546. PubMed ID: 32234417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
    Liu CJ; Chuang WL; Sheen IS; Wang HY; Chen CY; Tseng KC; Chang TT; Massetto B; Yang JC; Yun C; Knox SJ; Osinusi A; Camus G; Jiang D; Brainard DM; McHutchison JG; Hu TH; Hsu YC; Lo GH; Chu CJ; Chen JJ; Peng CY; Chien RN; Chen PJ
    Gastroenterology; 2018 Mar; 154(4):989-997. PubMed ID: 29174546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional study of real life data of HCV from Turkey south region.
    Suntur BM; Kaya H; Eker HBŞ; Kara B; Bozok T; Unal N
    J Infect Dev Ctries; 2020 Apr; 14(4):380-386. PubMed ID: 32379715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of universal access to direct-acting antiviral therapy on the hepatitis C cascade of care among individuals attending primary and community health services.
    Traeger MW; Pedrana AE; van Santen DK; Doyle JS; Howell J; Thompson AJ; El-Hayek C; Asselin J; Polkinghorne V; Membrey D; Bramwell F; Carter A; Guy R; Stoové MA; Hellard ME;
    PLoS One; 2020; 15(6):e0235445. PubMed ID: 32603349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.